Bill Steinkrauss

Bill Steinkrauss currently serves as Chief Financial Officer at ILiAD Biotechnologies, LLC and as Interim Chief Financial Officer at PureTech Health, while also leading OWL CFO Consulting as President, providing financial leadership to biotechnology companies. Previous roles include Chief Financial Officer at OcuTerra Therapeutics and Curis, where Bill also held the title of Chief Administrative Officer. Experience includes significant positions with OvaScience, Cubist Pharmaceuticals, and PwC, specializing in financial strategy, accounting, and capital markets. Bill holds a Bachelor of Science in Finance and Accounting and a Master of Science in Accounting from Boston College. Additionally, Bill contributes as a Board Member for COMPASS, Community Providers of Adolescent Services.